Treatment Options and Monitoring

Managing Epidermolysis Bullosa Acquisita (EBA) requires a long-term perspective and a high degree of patience. Because EBA is exceptionally rare, there is no single universally established “one-size-fits-all” treatment regimen. Much of the evidence for treatment comes from case reports, case series, or retrospective reviews rather than large randomized trials. Instead, your medical team will tailor your care based on the severity of your symptoms, whether your mucous membranes are involved, and how your body responds to initial therapies ^[1][2].

It is important to understand from the outset that EBA is often chronic and can be resistant to treatment. One recent review noted that the median time to remission—the point where the disease is inactive—was approximately 9 months, though response and relapse timing vary widely between individuals ^[3][4]. Follow-up should focus on measurable goals: fewer new blisters, better wound healing, controlled itch and pain, maintaining mucosal function, and minimizing medication side effects.

Treatment for Mild or Localized EBA

If your EBA is “low-risk” or localized to specific areas without involving the eyes or throat, your doctor may start with more conservative options. These treatments focus on reducing inflammation and protecting the skin from further damage.

• Topical Therapies: High-potency corticosteroid creams or topical immunomodulators (which calm the local immune response) are often used directly on blisters to speed up healing ^[1].
• Anti-inflammatory Agents: Drugs such as dapsone, colchicine, or certain antibiotics like doxycycline are frequently used ^[1][5]. While doxycycline is an antibiotic, in EBA it is used for its “anti-inflammatory” properties rather than to fight an infection ^[1].
• Wound Care: Protecting the skin from friction (trauma) is a critical part of management for the mechanobullous form of EBA, as minor injuries can trigger new blisters ^[1].

Treatment for Severe or Mucosal EBA

When EBA is widespread or affects “high-risk” areas like the eyes, mouth, esophagus, or airway, a more aggressive approach is necessary to prevent permanent scarring and loss of function ^[1][5].

Systemic Corticosteroids

Systemic corticosteroids (such as prednisone) are often used to quickly bring severe inflammation under control ^[1][6]. While effective for many, response is variable and treatment selection depends on specialist judgment. Because of potential side effects, doctors often add “steroid-sparing” immunosuppressants (like azathioprine or mycophenolate mofetil) to help lower the steroid dose over time ^[7].

Monitoring Medication Safety

Long-term use of systemic steroids and immunosuppressants requires careful monitoring. Do not start, stop, taper, or adjust these medicines without your prescriber.

Escalating Care: Biologics and Advanced Options

If EBA does not respond to standard steroids and immunosuppressants (a state known as refractory disease), your care team may suggest escalating to advanced, specialist-directed, and often off-label therapies.

Rituximab

Rituximab is a biologic medication given by infusion that targets and removes the B-cells responsible for producing the autoantibodies that attack your collagen ^[11].

• Efficacy: In a review of 31 small studies, many EBA patients showed a clinical response to Rituximab, and a majority achieved remission ^[11].
• Relapse: A substantial minority of patients experience a relapse after the initial treatment, meaning the disease becomes active again, often after an average of 23 months (though timing varies widely) ^[11].
• Side Effects: Mild, temporary reactions during the infusion are common. Serious risks include severe infections and Hepatitis B reactivation. It requires Hepatitis B screening before use and discussion of vaccination timing and hypogammaglobulinemia ^[11][12].

Intravenous Immunoglobulin (IVIG)

IVIG involves infusing highly concentrated antibodies collected from healthy donors. This treatment helps “neutralize” your own harmful autoantibodies ^[13].

• Efficacy: Small studies have shown remission in a majority of treated EBA patients ^[13].
• Regimen: A typical high-dose schedule involves infusions over 2 to 5 days, repeated every four weeks ^[14].
• Side Effects: Common side effects include headache, nausea, and fatigue. Rare but serious risks include blood clots (thrombosis) or kidney issues, which your team will monitor for closely ^[13][14].

The Importance of Multi-Specialty Care

Because EBA can affect multiple organ systems, your dermatologist may lead a “multidisciplinary team.” This might include an ophthalmologist (eye specialist) to prevent vision loss, a gastroenterologist (digestive specialist) if you have trouble swallowing, or an ENT specialist if your throat or airway is involved ^[5][15]. Coordinating these visits is essential to ensuring that scarring is caught and treated early ^[16][15].